Publishing research using ab33429? Please let us know so that we can cite the reference in this datasheet.

ab33429 has been referenced in 2 publications.

  • Viitala M  et al. Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8+ T-cell Response against Immunosuppressive Tumors. Clin Cancer Res N/A:N/A (2019). PubMed: 30755440
  • Kumar L  et al. Leucine-rich repeat containing 8A (LRRC8A) is essential for T lymphocyte development and function. J Exp Med 211:929-42 (2014). PubMed: 24752297

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up